These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15088771)

  • 1. Using the strains and getting the vaccine licensed--a vaccine manufacturer's view.
    Gerdil C
    Dev Biol (Basel); 2003; 115():17-21. PubMed ID: 15088771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The annual production cycle for influenza vaccine.
    Gerdil C
    Vaccine; 2003 May; 21(16):1776-9. PubMed ID: 12686093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influenza vaccine: globalization of public health stakes].
    Collin N; Briand S
    Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [WHO Influenza Global Agenda].
    Donatelli I; Pregliasco F
    Ann Ist Super Sanita; 2003; 39(3):425-33. PubMed ID: 15098565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Various sides of influenza. Part II--epidemiology, influenza surveillance and prophylaxis].
    Machała MK; Brydak LB
    Pol Merkur Lekarski; 2006 Sep; 21(123):277-85. PubMed ID: 17163191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Global influenza surveillance].
    Taniguchi K
    Nihon Rinsho; 2006 Oct; 64(10):1950-3. PubMed ID: 17037373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology transfer hub for pandemic influenza vaccine.
    Friede M; Serdobova I; Palkonyay L; Kieny MP
    Vaccine; 2009 Jan; 27(5):631-2. PubMed ID: 19022316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
    Jadhav S; Datla M; Kreeftenberg H; Hendriks J
    Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza in Taiwan: seasonality and vaccine strain match.
    Hsieh YC; Chen HY; Yen JJ; Liu DP; Chang LY; Lu CY; Shao PL; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2005 Aug; 38(4):238-43. PubMed ID: 16118670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary: From scarcity to abundance: pandemic vaccines and other agents for "have not" countries.
    Fedson DS; Dunnill P
    J Public Health Policy; 2007; 28(3):322-40. PubMed ID: 17717543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and progress of prepandemic and pandemic influenza vaccine development.
    Leroux-Roels I; Leroux-Roels G
    Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.